Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
eXmoor Pharma and Evox Therapeutics have completed a technology transfer program for Evox’s exosome-enabled gene editing platform, including its MSH3-targeted program for Huntington’s disease, at eXmoor’s Bristol, UK facility.
read more
Clinigen has appointed Greg Skalicky as Group Chief Executive Officer, effective July 20, 2026, succeeding Dr. Varun Sethi, who has served as Acting CEO since September 2025.
read more
Samsung Biologics has announced an all-cash public tender offer to acquire PolyPeptide Group AG, valuing the peptide-focused contract development and manufacturing organization at approximately CHF 1.46 billion.
read more
Circio Holding ASA and Avenue Biosciences have entered a research collaboration aimed at improving long-term expression and secretion of therapeutic proteins for gene and cell therapy applications.
read more
GemPharmatech and Humlab Global have signed a strategic agreement to distribute existing and novel humanized mouse strains worldwide, aiming to support more predictive in vivo testing for advanced therapeutics.
read more
Insilico Medicine and Bora Pharmaceuticals have announced a proposed multi-target strategic alliance that would link Insilico’s artificial intelligence–based discovery platform with Bora’s global development and manufacturing capabilities.
read more
Crown Bioscience announced it has joined Critical Path Institute's (C-Path) New Approach Methodologies Developer Coalition (NAMs-DC), a collaborative initiative dedicated to advancing the validation, qualification and regulatory adoption of ...
read more
Charles River Laboratories International announced a collaboration with Arovella Therapeutics, a biotechnology company, to provide Good Manufacturing Practice (GMP) Next Generation Sequencing (NGS) services for cell characterization.
read more
Formycon AG and OneSource Specialty Pharma have entered a strategic manufacturing partnership to support Formycon’s biosimilar programs for global markets.
read more
Valion Bio reported a set of strategic developments around its Toll like receptor 5 (TLR5) agonist Entolimod, underscoring plans to build an integrated biodefense and immunology platform rather than a single asset program.
read more
Kindeva announced the appointment of Brok Weichbrodt as Chief Transformation Officer to strengthen operational excellence, scale execution, and accelerate growth as the company enters the next phase of its value creation plan.
read more
Porton Advanced announced that its Umbilical Cord-Derived Mesenchymal Stem Cell (UC-MSCs) Cell Bank for exosome manufacturing has been accepted for filing by the FDA's Center for Biologics Evaluation and Research (CBER), under Drug Master File (DMF) ...
read more
Axplora reported updated EcoVadis sustainability ratings for four of its European manufacturing sites, with one site achieving platinum status and others receiving gold and silver ratings.
read more
WuXi Biologics has received FDA pre license inspection (PLI) approval for its MFG8 drug substance manufacturing facility in Hebei, clearing the way for commercial supply of a potential blockbuster autoimmune therapy.
read more
Evonik announced it is making a significant investment to strengthen manufacturing capabilities at its Tippecanoe Labs site in Lafayette, Indiana.
read more